Literature DB >> 15852369

Virus-delivered small RNA silencing sustains strength in amyotrophic lateral sclerosis.

Timothy M Miller1, Brian K Kaspar, Geert J Kops, Koji Yamanaka, Lindsey J Christian, Fred H Gage, Don W Cleveland.   

Abstract

Mutations in superoxide dismutase cause a subset of familial amyotrophic lateral sclerosis and provoke progressive paralysis when expressed in mice. After retrograde transport to the spinal cord following injection into muscles, an adeno-associated virus carrying a gene that encodes a small interfering RNA was shown to target superoxide dismutase messenger RNA for degradation. The corresponding decrease in mutant superoxide dismutase in spinal motor neurons preserved grip strength. This finding provides proof of principle for the selective reduction of any neuronal protein and supports intramuscular injections of a small interfering RNA-encoding virus as a viable therapy for this type of familial amyotrophic lateral sclerosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15852369      PMCID: PMC1351126          DOI: 10.1002/ana.20453

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  18 in total

1.  Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice.

Authors:  A M Clement; M D Nguyen; E A Roberts; M L Garcia; S Boillée; M Rule; A P McMahon; W Doucette; D Siwek; R J Ferrante; R H Brown; J-P Julien; L S B Goldstein; D W Cleveland
Journal:  Science       Date:  2003-10-03       Impact factor: 47.728

Review 2.  Killing the messenger: short RNAs that silence gene expression.

Authors:  Derek M Dykxhoorn; Carl D Novina; Phillip A Sharp
Journal:  Nat Rev Mol Cell Biol       Date:  2003-06       Impact factor: 94.444

3.  Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis.

Authors:  Hongliu Ding; Dianne S Schwarz; Alex Keene; El Bachir Affar; Laura Fenton; Xugang Xia; Yang Shi; Phillip D Zamore; Zuoshang Xu
Journal:  Aging Cell       Date:  2003-08       Impact factor: 9.304

4.  Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment.

Authors:  A Pramatarova; J Laganière; J Roussel; K Brisebois; G A Rouleau
Journal:  J Neurosci       Date:  2001-05-15       Impact factor: 6.167

5.  Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man.

Authors:  Lindsey R Fischer; Deborah G Culver; Philip Tennant; Albert A Davis; Minsheng Wang; Amilcar Castellano-Sanchez; Jaffar Khan; Meraida A Polak; Jonathan D Glass
Journal:  Exp Neurol       Date:  2004-02       Impact factor: 5.330

6.  Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease.

Authors:  Maria Maddalena Lino; Corinna Schneider; Pico Caroni
Journal:  J Neurosci       Date:  2002-06-15       Impact factor: 6.167

7.  AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B.

Authors:  Catherine S Manno; Amy J Chew; Sylvia Hutchison; Peter J Larson; Roland W Herzog; Valder R Arruda; Shing Jen Tai; Margaret V Ragni; Arthur Thompson; Margareth Ozelo; Linda B Couto; Debra G B Leonard; Frederick A Johnson; Alan McClelland; Ciaran Scallan; Erik Skarsgard; Alan W Flake; Mark A Kay; Katherine A High; Bertil Glader
Journal:  Blood       Date:  2002-12-19       Impact factor: 22.113

Review 8.  Unraveling the mechanisms involved in motor neuron degeneration in ALS.

Authors:  Lucie I Bruijn; Timothy M Miller; Don W Cleveland
Journal:  Annu Rev Neurosci       Date:  2004       Impact factor: 12.449

9.  Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model.

Authors:  Brian K Kaspar; Jerònia Lladó; Nushin Sherkat; Jeffrey D Rothstein; Fred H Gage
Journal:  Science       Date:  2003-08-08       Impact factor: 47.728

10.  RNA interference-mediated silencing of mutant superoxide dismutase rescues cyclosporin A-induced death in cultured neuroblastoma cells.

Authors:  Michele M Maxwell; Piera Pasinelli; Aleksey G Kazantsev; Robert H Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-23       Impact factor: 11.205

View more
  41 in total

1.  New treatments in amyotrophic lateral sclerosis.

Authors:  Nicholas Maragakis; Jeffrey D Rothstein
Journal:  Neuropsychopharmacology       Date:  2011-01       Impact factor: 7.853

Review 2.  RNA-targeted Therapeutics for ALS.

Authors:  Linga V Reddy; Timothy M Miller
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

3.  Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosis.

Authors:  Timothy M Miller; Soo H Kim; Koji Yamanaka; Mark Hester; Priya Umapathi; Hannah Arnson; Liza Rizo; Jerry R Mendell; Fred H Gage; Don W Cleveland; Brian K Kaspar
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-12       Impact factor: 11.205

Review 4.  Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease.

Authors:  Christian S Lobsiger; Don W Cleveland
Journal:  Nat Neurosci       Date:  2007-11       Impact factor: 24.884

5.  Artificial microRNAs as siRNA shuttles: improved safety as compared to shRNAs in vitro and in vivo.

Authors:  Ryan L Boudreau; Inês Martins; Beverly L Davidson
Journal:  Mol Ther       Date:  2008-11-11       Impact factor: 11.454

6.  Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis.

Authors:  Makoto Urushitani; Samer Abou Ezzi; Jean-Pierre Julien
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-02       Impact factor: 11.205

7.  Antisense oligonucleotide therapy for neurodegenerative disease.

Authors:  Richard A Smith; Timothy M Miller; Koji Yamanaka; Brett P Monia; Thomas P Condon; Gene Hung; Christian S Lobsiger; Chris M Ward; Melissa McAlonis-Downes; Hongbing Wei; Ed V Wancewicz; C Frank Bennett; Don W Cleveland
Journal:  J Clin Invest       Date:  2006-07-27       Impact factor: 14.808

Review 8.  Use of biomarkers in ALS drug development and clinical trials.

Authors:  Nadine Bakkar; Ashley Boehringer; Robert Bowser
Journal:  Brain Res       Date:  2014-10-24       Impact factor: 3.252

9.  Future of rAAV Gene Therapy: Platform for RNAi, Gene Editing, and Beyond.

Authors:  Paul N Valdmanis; Mark A Kay
Journal:  Hum Gene Ther       Date:  2017-01-10       Impact factor: 5.695

Review 10.  High content analysis in amyotrophic lateral sclerosis.

Authors:  Federica Rinaldi; Dario Motti; Laura Ferraiuolo; Brian K Kaspar
Journal:  Mol Cell Neurosci       Date:  2016-12-11       Impact factor: 4.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.